Mindfulness Therapy for Migraines
(TEAM-M Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether mindfulness therapy can help people with migraines. It compares three methods: over the phone, through video, and an online program called Mindfulness-Based Cognitive Therapy (MBCT). The researchers seek participants who experience migraines at least four days a month and have had them for over a year. Participants must be comfortable with English and able to use a headache diary regularly. The study aims to determine if these mindfulness techniques can reduce migraine pain and improve quality of life. As an unphased trial, it offers a unique opportunity to explore innovative mindfulness methods that could enhance well-being.
Do I have to stop taking my current medications for the trial?
The trial requires you to maintain stable dosages of your current acute or preventive medications for the study duration. If you've recently changed your migraine or antidepressant medications, you may not be eligible.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Mindfulness-Based Cognitive Therapy (MBCT) for migraines is generally safe and well-tolerated. Studies on MBCT delivered over the phone have found it practical and acceptable, with no major safety issues. One study noted its potential to reduce symptoms of depression, indicating positive mental health benefits.
For MBCT delivered via video, research has shown it to be a safe option that can effectively reduce headaches. Participants in these studies did not report any major side effects, making it a reliable choice for those interested in non-drug treatments.
Enhanced Usual Care (EUC), involving online modules, has also been found safe. While it may not improve all migraine-related symptoms, it helps reduce headache frequency without significant side effects.
Overall, these therapies are non-invasive, and existing studies support their safety for people looking to manage migraines.12345Why are researchers excited about this trial?
Researchers are excited about mindfulness therapy for migraines because it offers a convenient and accessible way to manage migraine symptoms. Unlike traditional treatments that often rely on medication, this approach uses mindfulness-based cognitive therapy (MBCT) to teach patients how to manage stress and pain through mental techniques. The therapy is delivered through online, telephone, and video formats, making it easy for participants to access from home without needing to visit a clinic. This flexibility and focus on mental health strategies could provide a valuable alternative or complement to existing migraine medications, potentially reducing dependency on drugs and empowering patients to take control of their symptoms.
What evidence suggests that this trial's treatments could be effective for migraines?
Studies have shown that Mindfulness-Based Cognitive Therapy (MBCT) can reduce the frequency of headaches in people with migraines. In this trial, participants may receive MBCT via video, which research indicates effectively lowers the impact of headaches on daily life. Another group will receive MBCT over the phone, which has shown evidence of reducing depression in individuals with long-term health issues, potentially benefiting those with migraines. Additionally, some participants will receive online MBCT programs, which have been found to lessen pain and stress-related symptoms. Overall, MBCT shows promise for easing migraine symptoms through these various delivery methods.15678
Who Is on the Research Team?
Elizabeth K Seng, Ph.D.
Principal Investigator
Albert Einstein College of Medicine and Yeshiva University
Amanda J Shallcross, M.P.H., N.D.
Principal Investigator
The Cleveland Clinic
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have migraines 4-14 days a month and mild to moderate depression. They must meet specific migraine criteria, be able to read/speak English, consent to participate, and keep a headache diary. Excluded are those with certain psychiatric conditions, recent changes in migraine or antidepressant medications, prior mindfulness therapy experience, daily meditation practice, or unstable medication use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Mindfulness-Based Cognitive Therapy (MBCT) via telephone, video, or Enhanced Usual Care (EUC) over 8 weeks
Follow-up
Participants are monitored for changes in depressive symptoms and migraine-specific quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Online
- Telephone
- Video
Find a Clinic Near You
Who Is Running the Clinical Trial?
Amanda Shallcross
Lead Sponsor
Albert Einstein College of Medicine
Lead Sponsor
Wake Forest University Health Sciences
Collaborator
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
Yeshiva University
Collaborator
The Cleveland Clinic
Collaborator